Decentralization Presents A Leap Forward For Clinical Trials

Forbes takes a look at the evolution and benefits of clinical trial decentralization.

Hawthorne Effect: The Gig Economy of Clinical Trials

Jodi Akin and Lisa Taxin Portner, CEO and physician's assistant at Hawthorne Effect, tell us how a gig economy model is benefitting clinical trials

Healthcare 'Heroes' Make Decentralized Clinical Trials Possible

A physician assistant from Hawthorne Effect shares how she and other trained health professionals contribute their knowledge and talents to in-home studies.

Startup Improves Clinical Trial Process To Ensure Better Healthcare For All

Jodi Akin, founder, chairman, and CEO at Hawthorne Effect, talks to Forbes about the future of  decentralized clinical trials (DCT) and their role in maximizing trial accessibility and trial data integrity.

3 Best Practices for Communicating with Patients During Clinical Trials

Three best practices for communicating with patients during clinical trials in order to build a trusting relationship and ensure a successful trial.

Hawthorne Effect Raises $20 Million Series A to Decentralize Clinical Trials

Jodi Akin, founder and CEO of Hawthorne Effect, discusses what comes next for the clinical trials company following a Series A funding round of $20 million.

Hawthorne Effect raises $20M with plans to disrupt the decentralized clinical trial space

Hawthorne was designed to help capture clinical trial data points beyond a single clinical setting. Its Hawthorne Cloud tool was developed with the goal of supporting researchers with trial recruitment, assessment development, capturing patient-reported outcomes, device data, and can help with interoperability efforts from all clinical visits, according to the company.

Decentralized format can elevate research: Hawthorne Effect

A leader from the virtual research solutions specialist discusses how a greater pushed toward home-based research can lead to a range of benefits.

Hawthorne finishes off $20M series A to boost cloud-based siteless trials work

Northpond Ventures, SignalFire and P5 Health Ventures have helped San Francisco-based clinical trial software firm Hawthorne Effect complete a $20 million first formal funding round.

Hawthorne Effect Raises $20 Million Series A Round of Financing to Decentralize Clinical Trials

Northpond Ventures leads round alongside SignalFire and P5 Health Ventures

About Hawthorne Effect

Hawthorne Effect decentralizes clinical trials, maximizing accessibility and data integrity. Our innovative approach combines licensed healthcare professionals with the latest connected technology to deliver decentralized clinical trials that are more efficient and accurate than the traditional trial model.


Let's start the conversation.

Scroll to Top